N
GWPH

Nuveen’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Nuveen’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,400
Closed -$2K – 3382
2020
Q3 		$2K Buy
+19,400
New +$2.23M ﹤0.01% 3288
2020
Q1 		– Sell
-33,700
Closed -$4K – 3285
2019
Q4 		$4K Buy
+33,700
New +$3.78M ﹤0.01% 3221

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen's GWPH Position: Q4 2020 in Review

Nuveen sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 92,786 shares — an estimated $9.03M sold.

Nuveen first reported a position in GWPH in Q2 2019 and held it in 6 quarters. The position peaked at $32.7M in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • Nuveen reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Nuveen sold 92,786 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $9.03M.
  • Nuveen first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 6 quarters.
  • Nuveen's GW Pharmaceuticals Plc American Depositary Shares position peaked at $32.7M in Q2 2019.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.